SCHEMBL29593185

SCHEMBL29593185

OCc1coc2c(OCc3ccncc3)cc(Br)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.52
PIM2 Q9P1W9 2/20 0.52
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
GLA P06280 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ABCB1 P08183 2/20 0.36
MAOA P21397 1/20 0.36
ACHE P22303 1/20 0.36
MAOB P27338 1/20 0.36
PTGER1 P34995 1/20 0.35
IKBKB O14920 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23219071 1.00 PIM1 (0.52) PIM1PIM2ALDH1A1HTTSMN1; SMN2
SCHEMBL23218493 0.81 ABCB1 (0.39) ABCB1PRKDC
SCHEMBL23218148 0.79 MEN1 (0.33) PIM1PIM2ACHEMAOBKMT2A
SCHEMBL23218355 0.78 PIM1 (0.52) PIM1PIM2ALDH1A1SMN1; SMN2NPSR1
SCHEMBL29852957 0.78 PIM1 (0.52) PIM1PIM2ALDH1A1SMN1; SMN2NPSR1
SCHEMBL29852821 0.77 PIM1 (0.44) PIM1PIM2ALDH1A1HTTSMN1; SMN2
SCHEMBL23218979 0.76 MAP4K3 (0.32)
SCHEMBL23218736 0.76 GRM2 (0.39) PTGER1
SCHEMBL23218834 0.76 S1PR1 (0.30) PIM1PIM2
SCHEMBL23218340 0.74 PDE4A (0.40) PIM1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
CN-114502168-A Oral complement factor D inhibitors 拜奥克里斯特制药公司 2022-05-13 CN disclosed